CA2522166C - Muteine d'integrase lambda pour utilisation en recombinaison - Google Patents

Muteine d'integrase lambda pour utilisation en recombinaison Download PDF

Info

Publication number
CA2522166C
CA2522166C CA2522166A CA2522166A CA2522166C CA 2522166 C CA2522166 C CA 2522166C CA 2522166 A CA2522166 A CA 2522166A CA 2522166 A CA2522166 A CA 2522166A CA 2522166 C CA2522166 C CA 2522166C
Authority
CA
Canada
Prior art keywords
dna
cells
aces
gene
site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2522166A
Other languages
English (en)
Other versions
CA2522166A1 (fr
Inventor
Edward Perkins
Carl Perez
Michael Lindenbaum
Amy Greene
Josephine Leung
Elena Fleming
Sandra Stewart
Joan Shellard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority claimed from CA002441937A external-priority patent/CA2441937A1/fr
Publication of CA2522166A1 publication Critical patent/CA2522166A1/fr
Application granted granted Critical
Publication of CA2522166C publication Critical patent/CA2522166C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention porte sur une mutéine d'intégrase lambda utilisée en recombinaison. L'une des applications utiles de cette mutéine est le chromosome artificiel, y compris Aces. Ces chromosomes ont été conçus pour subir une recombinaison-intégration d'un ADN d'intérêt décrit dans l'invention, ayant lieu à un site spécifique. Ces chromosomes artificiels permettent un génie adaptable, efficient et rationnel du chromosome.
CA2522166A 2001-05-30 2002-05-30 Muteine d'integrase lambda pour utilisation en recombinaison Expired - Fee Related CA2522166C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US29475801P 2001-05-30 2001-05-30
US60/294,758 2001-05-30
US36689102P 2002-03-21 2002-03-21
US60/366,891 2002-03-21
CA002441937A CA2441937A1 (fr) 2001-05-30 2002-05-30 Plate-formes basees sur des chromosomes

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002441937A Division CA2441937A1 (fr) 2001-05-30 2002-05-30 Plate-formes basees sur des chromosomes

Publications (2)

Publication Number Publication Date
CA2522166A1 CA2522166A1 (fr) 2002-12-05
CA2522166C true CA2522166C (fr) 2011-05-03

Family

ID=35452393

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2522166A Expired - Fee Related CA2522166C (fr) 2001-05-30 2002-05-30 Muteine d'integrase lambda pour utilisation en recombinaison

Country Status (1)

Country Link
CA (1) CA2522166C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016022075A1 (fr) * 2014-08-08 2016-02-11 Agency For Science, Technology And Research Mutants de l'intégrase du bactériophage lambda

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118620855B (zh) * 2024-06-20 2025-09-26 南京大学 一种乙醛脱氢酶的突变体及其制备方法和应用

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016022075A1 (fr) * 2014-08-08 2016-02-11 Agency For Science, Technology And Research Mutants de l'intégrase du bactériophage lambda

Also Published As

Publication number Publication date
CA2522166A1 (fr) 2002-12-05

Similar Documents

Publication Publication Date Title
US20030119104A1 (en) Chromosome-based platforms
AU2022200903C1 (en) Engineered Cascade components and Cascade complexes
AU2019203955B2 (en) Multipartite signaling proteins and uses thereof
KR102319845B1 (ko) 조류 숙주 세포에 대한 crispr-cas 시스템
KR20230091894A (ko) 부위 특이적 표적화 요소를 통한 프로그램 가능한 첨가(paste)를 사용하는 부위 특이적 유전 공학을 위한 시스템, 방법, 및 조성물
ES2819976T5 (es) Composiciones y usos médicos para la reprogramación de TCR con proteínas de fusión
US20040003420A1 (en) Modified recombinase
CN113396222A (zh) 腺相关病毒(aav)生产细胞系和相关方法
KR20240029020A (ko) Dna 변형을 위한 crispr-트랜스포손 시스템
JP2003534775A (ja) タンパク質を不安定化する方法とその使用
KR20230019063A (ko) C9orf72 연관 질환의 치료를 위한 삼중 기능 아데노-연관 바이러스 (aav) 벡터
CN111094569A (zh) 光控性病毒蛋白质、其基因及包含该基因的病毒载体
CN112877292A (zh) 产生人抗体的细胞
KR20240021906A (ko) 발현 벡터, 박테리아 서열-무함유 벡터, 및 이를 제조하고 사용하는 방법
KR20230117327A (ko) 가용성 알칼리성 포스파타제 작제물 및 가용성 알칼리성 포스파타제 작제물을 인코딩하는 폴리뉴클레오티드를 포함하는 발현 벡터
AU2017233862B2 (en) Methods and compositions for increased double stranded RNA production
AU2024217163A1 (en) Transposase, transposon, transposon system, and use thereof
AU2023265204A1 (en) Virus-derived construct plasmid library and construction of same
KR20160003691A (ko) Opa1 단상부족에 의해 원인이 되는 질병 치료를 위한 인공전사인자
KR20240022571A (ko) Rna-가이드된 이펙터 동원을 위한 시스템, 방법 및 성분
WO2002038613A2 (fr) Recombinase modifiee
CA2522166C (fr) Muteine d'integrase lambda pour utilisation en recombinaison
US20210130818A1 (en) Compositions and Methods for Enhancement of Homology-Directed Repair Mediated Precise Gene Editing by Programming DNA Repair with a Single RNA-Guided Endonuclease
US11814412B2 (en) Artificial proteins and compositions and methods thereof
CN117881788A (zh) 表达载体、无细菌序列载体及其制备和使用方法

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20220301

MKLA Lapsed

Effective date: 20200831